SolasCure publishes Dose Escalation Study on painless application of Aurase Wound Gel

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the publication of a peer-reviewed study in the International Wound Journal.